Publisher
Springer International Publishing
Reference119 articles.
1. Abreu MT, Fukata M, Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 174:4453–4460
2. Adelaja AO, Schilling BJ (1999) Nutraceutical: blurring the line between food and drugs in the twenty-first century. Mag Food Farm Resour Issues 14:35–40
3. Ananthakrishnan AN, Khalili H, Konijeti GG et al (2014) Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut 63:776–784
4. Arita M, Yoshida M, Hong S et al (2005) Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2, 4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA 102:7671–7676
5. Aslan A, Triadafilopoulos G (1992) Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 87:432–437